Dr Suchithra A Nancherla, M D | |
103 W Broad St, Suite# 120, Falls Church, VA 22046-4235 | |
(703) 534-6002 | |
(703) 534-7472 |
Full Name | Dr Suchithra A Nancherla |
---|---|
Gender | Female |
Speciality | Endocrinology |
Experience | 43 Years |
Location | 103 W Broad St, Falls Church, Virginia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1851312995 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 010141874 (Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Virginia Hospital Center | Arlington, VA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Privia Medical Group Llc | 4385682061 | 1176 |
News Archive
A new study identifies specific locations where medication and harm reduction services for people with opioid use disorder should be available in order to have the greatest impact on reducing opioid overdose deaths.
FibroGen, Inc., today announced results of a 2-year clinical study demonstrating that surgical implantation of biosynthetic corneas formulated with the company's proprietary recombinant human type III collagen (rhCIII) restored vision and promoted nerve regeneration (restoring sensitivity) in patients who had corneal damage and significant vision loss.
Children with sickle cell disease who also have lower blood oxygen levels while both asleep and awake are likely to have heart abnormalities, researchers at Washington University School of Medicine in St. Louis and other institutions have found.
In a new study by researchers in the UK, the activity of neutralizing antibodies collected from the sera of individuals that contracted COVID-19 during the first wave of the pandemic is tested against variants of concern the B.1.1.7 (or UK) variant and the B.1.351 (or South African) variant, demonstrating somewhat reduced potency of neutralization towards these strains.
Lung transplantation can prolong the lives of patients with end-stage lung disease, but the median survival rate after lung transplant is less than six years, which has improved only slightly in recent decades.
› Verified 4 days ago
Entity Name | Privia Medical Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013042480 PECOS PAC ID: 4385682061 Enrollment ID: O20050422000298 |
News Archive
A new study identifies specific locations where medication and harm reduction services for people with opioid use disorder should be available in order to have the greatest impact on reducing opioid overdose deaths.
FibroGen, Inc., today announced results of a 2-year clinical study demonstrating that surgical implantation of biosynthetic corneas formulated with the company's proprietary recombinant human type III collagen (rhCIII) restored vision and promoted nerve regeneration (restoring sensitivity) in patients who had corneal damage and significant vision loss.
Children with sickle cell disease who also have lower blood oxygen levels while both asleep and awake are likely to have heart abnormalities, researchers at Washington University School of Medicine in St. Louis and other institutions have found.
In a new study by researchers in the UK, the activity of neutralizing antibodies collected from the sera of individuals that contracted COVID-19 during the first wave of the pandemic is tested against variants of concern the B.1.1.7 (or UK) variant and the B.1.351 (or South African) variant, demonstrating somewhat reduced potency of neutralization towards these strains.
Lung transplantation can prolong the lives of patients with end-stage lung disease, but the median survival rate after lung transplant is less than six years, which has improved only slightly in recent decades.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Suchithra A Nancherla, M D 103 W Broad St, Suite# 120, Falls Church, VA 22046-4235 Ph: (703) 534-6002 | Dr Suchithra A Nancherla, M D 103 W Broad St, Suite# 120, Falls Church, VA 22046-4235 Ph: (703) 534-6002 |
News Archive
A new study identifies specific locations where medication and harm reduction services for people with opioid use disorder should be available in order to have the greatest impact on reducing opioid overdose deaths.
FibroGen, Inc., today announced results of a 2-year clinical study demonstrating that surgical implantation of biosynthetic corneas formulated with the company's proprietary recombinant human type III collagen (rhCIII) restored vision and promoted nerve regeneration (restoring sensitivity) in patients who had corneal damage and significant vision loss.
Children with sickle cell disease who also have lower blood oxygen levels while both asleep and awake are likely to have heart abnormalities, researchers at Washington University School of Medicine in St. Louis and other institutions have found.
In a new study by researchers in the UK, the activity of neutralizing antibodies collected from the sera of individuals that contracted COVID-19 during the first wave of the pandemic is tested against variants of concern the B.1.1.7 (or UK) variant and the B.1.351 (or South African) variant, demonstrating somewhat reduced potency of neutralization towards these strains.
Lung transplantation can prolong the lives of patients with end-stage lung disease, but the median survival rate after lung transplant is less than six years, which has improved only slightly in recent decades.
› Verified 4 days ago
Amita Rajani, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 3300 Gallows Road Inova Fairfax Medical Campus, Department Of Medicine, Npt-2, Falls Church, VA 22042 Phone: 703-776-7780 | |
Dr. Mary Beck O'donnell, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 2960 Sleepy Hollow Rd, Falls Church, VA 22044 Phone: 703-536-2000 Fax: 703-536-4256 | |
Lindsey A. Cilia, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2901 Telestar Ct Ste 200, Falls Church, VA 22042 Phone: 703-573-3494 Fax: 703-573-5353 | |
Chin Hee Kim, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd Dept Of, Falls Church, VA 22042 Phone: 703-776-3582 | |
Candyce Heather Greene, MD, MPH, MSW Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-4001 Fax: 703-776-7113 | |
Dr. Megan Elizabeth Terek, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-4001 Fax: 703-776-7113 | |
Dr. Hazim El-haddad, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2901 Telestar Ct Ste 200, Falls Church, VA 22042 Phone: 703-573-3494 Fax: 703-573-5353 |